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Introduction: Toxoplasma gondii is an intracellular parasite that causes severe disease when the infection
occurs during pregnancy. Trophoblast cells constitute an important maternalefetal barrier, with
monocytes concentrating around them. Thus, interactions between trophoblasts and monocytes are
important for maintaining a successful pregnancy, especially in cases of infection. This study aimed to
evaluate the role of trophoblast cells (BeWo line) on monocyte (THP-1 line) activity in the presence or
absence of T. gondii infection.
Methods: THP-1 cells were stimulated with supernatants of BeWo cells, previously infected or not with
T. gondii, and then infected with parasites. The supernatant of both cells were collected and analyzed for
cytokine production and T. gondii proliferation in THP-1 cells was determined.
Results: The results showed that after infection, the pattern of cytokines secreted by THP-1 and BeWo
cells was characterized as a pro-inﬂammatory proﬁle. Furthermore, supernatant of BeWo cells infected or
not, was able to change the cytokine proﬁle secreted by infected THP-1 cells, and this supernatant
became THP-1 cells more able to control T. gondii proliferation than those that had not been stimulated.
Discussion: This effect was associated with secretion of interleukin (IL)-6 by the THP-1 cells and soluble
factors secreted by BeWo cells, such as IL-6 and MIF.
Conclusion: Together, these results suggest that trophoblast cells are able to modulate monocyte activity,
resulting in the control of T. gondii infection and subsequent maintenance of pregnancy.
 2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Toxoplasma gondii is the etiologic agent of toxoplasmosis,
a disease that is usually asymptomatic in immunocompetent
individuals, but can be severe in immunocompromised patients
and cases of congenital toxoplasmosis [1,2]. The main defense
mechanism against T. gondii is mediated by a T helper type 1 (Th1)-
immune response characterized by secretion of pro-inﬂammatory
cytokines [3]. During pregnancy, the maternal immune responsex: þ55 34 3218 2333.
.S. Castro), celeneoliveira@
o.com.br (M.B. Angeloni),
, bellisafb@yahoo.com.br
o), deiseaosilva@pq.cnpq.br
rtins-Filho), jrmineo@ufu.br
o), eloisa@umuarama.ufu.br
sevier OA license.shifts to a T helper type 2 (Th2) proﬁle, with predominant secretion
of anti-inﬂammatory cytokines, which allow fetal tolerance and
maintenance of pregnancy [4,5]. However, this anti-inﬂammatory
microenvironment becomes favorable to parasite replication,
including T. gondii [6,7].
Several cellular components of the innate immune system are
found at the site of embryo implantation. Monocytes constitute
20e30% of this population and remain present at high levels
throughout pregnancy [8]. Previous studies demonstrated that
trophoblast cells express pattern recognition receptors that
recognize the presence of bacteria, viruses, parasites or dying
cells, and then secrete cytokines and chemokines able to act on
cells of the innate immune system present in the deciduas; for
example, inducing the recruitment, differentiation and activity of
monocytes [8,9]. Consequently, monocytes within the decidua
accumulate around the invading trophoblast cells and acquire an
activated phenotype that is important for the clearance of
apoptotic cells and cellular debris, thus facilitating trophoblast
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the innate immune cells may play an important role in ﬁne-tuning
fetalematernal immune responses and consequently in successful
pregnancy.
Clinical studies, however, have established a strong association
between pregnancy complications and intrauterine infections as
a result of the interaction between trophoblast cells and innate
immune cells [12,13]. Receptors present in trophoblast cells are able
to recognize the presence of pathogens, followed by secretion of
cytokines that act upon the innate immune cells within the decidua
[14]. Therefore, theway that these cells interact with each other can
be decisive to the tolerance of allogeneic fetus and the host defense
against possible infections.
Monocytes are one of the major cells of the innate immune
system responsible for the control as well as dissemination of
T. gondii during the acute phase of infection, including at the
maternalefetal interface [15,16]. In this regard, our previous study
veriﬁed that human villous explants from ﬁrst trimester pregnan-
cies expressed high levels of intercellular adhesion molecule 1
(ICAM-1) that favored increased adhesion of monocytes to
trophoblast cells, favoring dissemination of the infection into the
deep placental tissues [16]. Thus, this study aimed to investigate if
factors secreted by trophoblasts inﬂuence cytokine production and
T. gondii control by monocytes, through in vitro experiments using
well established cell lines.
2. Materials and methods
2.1. Cell culture
BeWo and THP-1 cell lines obtained from American Type Culture Collection
(ATCC, Manassas, VA, USA) were cultured in RPMI-1640 medium (Gibco, Paisley,
UK), supplemented with 25 mM HEPES, 100 U/mL penicillin, 100 mg/mL strepto-
mycin (all reagents from SigmaeAldrich, St. Louis, MO, USA) and 10% heat-
inactivated fetal calf serum (FCS) (Cultilab, Campinas, Brazil) e complete medium
e in a humidiﬁed incubator at 37 C with 5% CO2 [17].
2.2. Parasites
Tachyzoites of the T. gondii 2F1 RH strain, which constitutively express cyto-
plasmic b-galactosidase, were a gift from Dr. Vern Carruthers, Medicine School of
Michigan University (USA). The parasites were propagated in BeWo cells cultured in
RPMI 1640 medium supplemented with penicillin, streptomycin and 2% FCS at 37 C
and 5% CO2.
2.3. Treatment of THP-1 cells with supernatants of BeWo cells
BeWo cells were cultured in 96-well plates (1  105 cells/200 mL/well) in
complete medium for 24 h at 37 C and 5% CO2. Cells were then infected with
tachyzoites of T. gondii at a 3:1 (parasites: host cell) ratio or incubated only with
medium (control). After incubation for 24 h at 37 C and 5% CO2, the plates were
centrifuged (720 g, 10 min) and the cell-free supernatants were collected and stored
at 80 C until used for cytokine detection and treatment of THP-1 cells.
THP-1 cells were cultured in 96-well plates (1  1105 cells/200 mL/well) in
complete medium for 24 h at 37 C and 5% CO2 and then treated with the uninfected
or infected BeWo supernatants (conditioned medium). As a control, THP-1 cells
were cultured only with complete medium. After 24 h of treatment, the cell
supernatants were removed and complete medium was added to the wells. THP-1
cells were then infected with tachyzoites (3:1; parasites: cells) and incubated for
24 h at 37 C and 5% CO2. The plates were centrifuged (720 g, 10 min) and the cell-
free supernatants were collected and stored at 80 C for cytokine detection.
2.4. Measurement of cytokines secreted by THP-1 and BeWo cells
2.4.1. Enzyme-linked immunosorbent assay (ELISA)
Human cytokines (IL-12, TGF-b1 andMIF) were measured in the supernatants of
THP-1 and BeWo cells by sandwich ELISAs according to the manufacturer’s
instructions (R&D Systems, Minneapolis, MN, USA). The sensitivity limits of these
assays were 7.8 pg/mL for IL-12, and 25 pg/mL for TGF-b1 and MIF.
2.4.2. Cytometric bead array (CBA)
Human cytokines (IL-2, IFN-g, TNF-a, IL-6, IL-4, IL-10 and IL-17A) were
measured in the supernatants of THP-1 and BeWo cells by cytometric bead array(CBA, BD Biosciences, San Jose, CA, USA), using the Th1/Th2/Th17 kit (BD Biosci-
ence), according to the manufacturer’s instructions. The samples were analyzed
under BD ﬂow cytometry (FACSCalibur, BD Company, San Diego, CA, USA) and
the data were calculated using a specialized software (BD Cell Quest and CBA
software).
2.5. T. gondii proliferation assay in THP-1 cells
THP-1 cells were cultured in 96-well plates (2  104 cells/200 mL/well) at 37 C
and 5% CO2 for 24 h and then stimulated with the uninfected or infected BeWo
supernatants or with complete medium alone for 24 h. Subsequently, the super-
natants were removed and the THP-1 cells were infectedwith tachyzoites of T. gondii
(3:1; parasites: cell) and incubated for 24 h at 37 C and 5% CO2. The plates were
centrifuged (720 g, 10 min), the supernatants removed and the cells analyzed for
T. gondii intracellular proliferation using a colorimetric b-galactosidase assay as
previously described [18].
In a second set of experiments, THP-1 cells were cultured for 24 h as described
above. Next, T. gondii tachyzoites were added to cells (3:1) and, after 4 h of infection,
the cells were washed and treated with polyclonal rabbit anti-human IL-6 antibody
(Peprotech Inc., RockyHill, USA) at 10 mg/mL. As controls, infected cells were treated
with medium or 10 mg/mL of an irrelevant polyclonal rabbit IgG antibody (Jackson
Immuno Research, West Grove, USA). After 24 h of treatment T. gondii intracellular
proliferation was determined [18].
In another set of experiments, THP-1 cells were cultured into 96-well plates
(2  104 cells/200 mL/well) for 24 h at 37 C and 5% CO2. The cells were then stim-
ulated with supernatants of BeWo cells, infected or not, previously neutralized with
10 mg/mL of anti-IL-6 (Peprotech), anti-MIF (R&D Systems) or anti-TGF-b1 (R&D
Systems) antibodies for 2 h at 37 C and 5% CO2. After 24 h of stimulation, THP-1 cells
were infected with T. gondii tachyzoites (3:1) for additional 24 h. As controls, THP-1
cells were stimulated with non-neutralized BeWo cell supernatant or neutralized
with 10 mg/mL of an irrelevant polyclonal rabbit IgG antibody (Jackson Immuno
Research), and then infected with T. gondii. After 24 h of infection, T. gondii intra-
cellular proliferation was determined [18].
Finally, THP-1 cells were cultured into 96-well plates (2  104 cells/200 mL/
well) for 24 h at 37 C and 5% CO2. Cells were washed three times with in complete
medium and then treated separately with human recombinant cytokines: rIL-6
(PeproTech) at 25, 50 and 100 pg/mL, rMIF (BDBioscience) at 2000, 4000 and
8000 pg/mL and rTGF-b1 (R&D Systems) at 500, 1000 and 2000 pg/mL for addi-
tional 24 h at 37 C and 5% CO2. Next, T. gondii tachyzoites were added to the cells
(3:1) and, after 3 h of infection, the cells were washed with medium and again
treated with the cytokines in the same concentrations. As controls, cells were
infected and treated with medium only. After 24 h of treatment, parasite prolif-
eration was measured [18].
T. gondii intracellular proliferation datawere expressed as number of tachyzoites
calculated in relation to the reference curve of 2F1 strain tachyzoites, ranging from
1  106 to 15.625  103 total parasites.
2.6. Analysis of cytokine signatures
Complementary “non-conventional” analysis of cytokine data was applied to
evaluate the cytokine proﬁle in the supernatant from each experimental condition,
using the general concept of “low” and “high” cytokine levels as previously proposed
by Luiza-Silva et al. [19]. For this purpose, the whole data universe of cytokine levels
in the supernatants (pg/mL) recorded for all experimental groups was used to
calculate the global median value for each cytokine. The global median values were
used as the cut-off edge to tag each individual supernatant as it presents “low” or
“high” levels of cytokines. Following, the frequency (%) of supernatant showing
“high levels of cytokine” (above the global median cut-off) was calculated in order to
determine the percentage of experimental conditions displaying high levels of
cytokines. The “cytokine signature” for each experimental condition was then
assembled as an ascendant curve of frequencies of high cytokine levels for each
experimental condition. The comparative analysis of cytokine signatures was per-
formed using the 50th percentile as a limit to identify the cytokines considered
relevant on each experimental condition. In order to highlight the relevant differ-
ences between experimental groups, we have used gray rectangles to stretch the
distinctive cytokines icon from each cytokine signature. This approach showed to be
relevant to detect subtle changes in the cytokine signatures not detectable by
conventional statistical approaches. The value of this non-conventional “qualitative-
observational” method was emphasized during data analysis, as the patterns of
cytokine signature were consistent with the parasite growth observed in parallel
experiments.
2.7. Statistical analyses
Statistical analyses were carried out using GraphPad Prism 5.0 (GraphPad
Software Inc., San Diego, CA, USA). Data were expressed as mean  standard devi-
ation (SD) of two to three independent experiments performed in triplicate. Data
were compared using the Student’s t test. Differences were considered statistically
signiﬁcant when P < 0.05.
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3.1. THP-1 and BeWo cells infected with T. gondii preferentially
secrete pro-inﬂammatory cytokines
The cytokine proﬁles secreted by THP-1 and BeWo cells, infected
or not with T. gondii, are illustrated in Fig. 1. The infected THP-1 and
BeWo cells secreted higher levels of pro-inﬂammatory cytokines
(MIF, IL-12 and IL-6) (Fig. 1AeC) and lower levels of the anti-
inﬂammatory cytokine (TGF-b1) (Fig. 1E) than uninfected cells.
However, the cytokine proﬁlewas different for IL-10 and IL-17A, with
lower IL-10 levels secreted by infected THP-1 cells (Fig. 1F) and lowerFig. 1. Secretion of cytokines by THP-1 and BeWo cells infected with T. gondii. The results are
TGF-b1; and in MFI (mean of ﬂuorescence intensity) when measured by ﬂow cytometry: (C)
control. Data are expressed as mean  SD of two independent experiments performed in
Student’s t test).IL-17A levels secreted by infected BeWo cells (Fig. 1D) compared to
their respective uninfected cells.
The cytokine signatures emphasize the predominance of pro-
inﬂammatory responses in THP-1 and BeWo cells infected with
T. gondii (Fig. 2). Thus, uninfected THP-1 cells showed an anti-
inﬂammatory response proﬁle, with relevant frequency of IL-10
and TGF-b1 and, after infection, these cells changed to a pro-
inﬂammatory response, with relevant frequency of IL-12, MIF
and IL-17A (Fig. 2A). In uninfected BeWo cells, the cytokines
with relevant frequency were TGF-b1 and IL-17A. After infection,
the predominant cytokines were IL-12, MIF, IL-6 and IL-10
(Fig. 2B).expressed in pg/mL when cytokines were measured by ELISA: (A) MIF, (B) IL-12 and (E)
IL-6, (D) IL-17A and (F) IL-10. THP-1 and BeWo cells not infected with T. gondii served as
triplicate. *Signiﬁcant differences in relation to the control in each cell line (P < 0.05;
Fig. 2. Cytokine signatures secreted by THP-1 and BeWo cells infected or not with T. gondii. The results are expressed as frequency of high cytokine levels (%) calculated from the
global medians for each cytokine, which were then used as cut-off. Frequencies were considered relevant when higher than 50%.
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inﬂammatory cytokines by THP-1 cells
THP-1 cells, infected or not, secreted higher levels of MIF and IL-
12 when stimulated with supernatant from infected than unin-
fected BeWo cells (Fig. 3AeB). In infected THP-1 cells, however, the
secretion of MIF and IL-12 was even higher when the cells were not
stimulated in comparison to the cells stimulated with both super-
natants from BeWo cells (Fig. 3AeB).
THP-1 cells, infected or not, secreted more IL-6 after stimulus
with the supernatants from BeWo cells, especially with the infected
BeWo cell supernatant (Fig. 3C). The secretion of IL-17A by unin-
fected THP-1 cells was not altered by any stimulus (Fig. 3D), but
after infection, THP-1 cells secreted higher levels of IL-17A when
stimulatedwith supernatant of infected than uninfected BeWo cells
(Fig. 3D).
THP-1 cells, infected or not, secreted lower levels of TGF-b1
when stimulated with the supernatants of BeWo cells than the
control, mainly with the infected BeWo cell supernatant (Fig. 3E). In
contrast, the secretion of IL-10was higher in THP-1 cells, infected or
not, when stimulated with the BeWo cell supernatants than the
control, and this secretion was even higher after stimulus with
infected BeWo cell supernatant (Fig. 3F).
The analysis of the cytokine signatures revealed that unin-
fected THP-1 cells, when stimulated with supernatant from
infected BeWo cells, showed a predominantly pro-inﬂammatory
proﬁle, with higher frequencies of IL-6 and IL-12 compared with
the other stimuli, which induced an anti-inﬂammatory response
(IL-10 and TGF-b1) (Fig. 4A). On the other hand, infected THP-1
cells exhibited a pro-inﬂammatory cytokine proﬁle regardless of
the stimulus, with relevant frequency of IL-12, IL-17A, IL-6 and
MIF after stimulus with infected BeWo cell supernatant, MIF and
IL-6 after stimulus with uninfected supernatant, and IL-12, MIF
and IL-17A in the absence of stimulus (Fig. 4B).
The levels of IL-2, IL-4, TNF-a and IFN-g were also analyzed by
ﬂow cytometry, but the results were below the detection limit of
the assays (data not shown).3.3. THP-1 cells are more able to control T. gondii proliferation
when stimulated with BeWo cell supernatants
When stimulated with uninfected or infected BeWo cell super-
natants, THP-1 cells weremore able to control T. gondii proliferationthan non-stimulated cells (Fig. 5A). Furthermore, the proliferation
of T. gondii was even lower in THP-1 cells stimulated with infected
than uninfected BeWo cell supernatants (Fig. 5A).
3.4. IL-6 and parasitism are inversely associated in THP-1 cells
stimulated with BeWo cell supernatants
To investigate if the control of T. gondii proliferation was asso-
ciated with the cytokine proﬁle secreted by the THP-1 cells, the
relationship between the number of tachyzoites and each cytokine
was analyzed. Among the analyzed cytokines, IL-6 showed a rele-
vant inverse associationwith the number of tachyzoites, since THP-
1 cells infected after stimulus with supernatants from infected or
non-infected BeWo cells secreted higher levels of IL-6 and were
more able to control T. gondii proliferation than the control cells
(Fig. 5B). For the remaining cytokines, no relationship between the
parasitism and cytokine proﬁle secreted by THP-1 cells was found
(data not shown). These ﬁndings were corroborated when IL-6 was
neutralized with a speciﬁc antibody, since THP-1 cells pretreated
with anti-IL-6 antibody showed a higher number of tachyzoites
than untreated THP-1 cells (Fig. 5C) or treated with an irrelevant
antibody (data not shown).
3.5. MIF and IL-6 secreted by BeWo cells are involved in the control
of parasitism in THP-1 cells
As MIF, IL-6 and TGF-b1 were the most secreted cytokines by
BeWo cells, the supernatants of BeWo cells, infected or not with
T. gondii, were ﬁrst neutralized with each speciﬁc antibody and the
parasitism in THP-1 cells treated with these supernatants was
evaluated (Fig. 6A). THP-1 cells stimulated with uninfected or
infected BeWo cell supernatants and neutralized with anti-IL-6 or
anti-MIF antibodies showed higher number of tachyzoites than
untreated controls or those neutralized with irrelevant antibody
(Fig. 6A). Differently, THP-1 cells stimulated with uninfected or
infected BeWo cell supernatants and neutralized with anti-TGF-b1
antibody had a parasitism index similar to the untreated control
and to the cells neutralized with an irrelevant antibody (Fig. 6A).
These ﬁndings were corroborated when THP-1 cells were treated
with rIL-6 or rMIF, showing that parasitism was reduced with the
highest concentration of IL-6 (100 pg/mL) and the lowest concen-
tration of MIF (2000 and 4000 pg/mL) compared with the control
(Fig. 6B). Furthermore, THP-1 cells treated with TGF-b1 at 500 pg/
Fig. 3. Secretion of cytokines by THP-1 cells, infected or not with T. gondii, after stimulation with supernatants from uninfected or infected BeWo cells. The results are expressed in
pg/mL when cytokines were measured by ELISA: (A) MIF, (B) IL-12 and (E) TGF-b1; and in MFI (mean of ﬂuorescence intensity) when they were measured by ﬂow cytometry: (C) IL-
6, (D) IL-17A and (F) IL-10. THP-1 cells, infected or not with T. gondii, without stimulus with supernatants from uninfected or infected BeWo cells served as control. Data are
expressed as mean  SD of two independent experiments performed in triplicate. (*) Signiﬁcant differences in relation to the control in each condition; (C) signiﬁcant differences
between non-infected and infected BeWo cell supernatants in each condition (P < 0.05; Student’s t test).
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than the control (Fig. 6B).
4. Discussion
During pregnancy, immunological changes are necessary to
maintain its normal course [8]. Previous studies demonstrated that
trophoblast cells promote fetal acceptance under normal condi-
tions, but may initiate signals promoting fetal rejection in the
presence of infection by agents such as T. gondii [20,21]. Monocytes
are the main cells used by T. gondii for its dissemination and, during
pregnancy, these cells are attracted to the placental microenvi-
ronment by trophoblast cells [10]. Therefore, it is possible that the
presence of monocytes at thematernalefetal interface can facilitate
the vertical transmission of this parasite for the embryos [15].
In the present study, we showed that T. gondii-infected THP-1
and BeWo cells secreted increased levels of pro-inﬂammatory
cytokines (MIF, IL-12 and IL-6) and had reduced production of
anti-inﬂammatory cytokines (TGF-b1). Thus, this pro-inﬂammatory
proﬁle may represent a mechanism associated with the control of
the infection as observed in other studies [22e24]. We also showed
that THP-1 cells, when stimulated with supernatants from non-infected BeWo cells, secreted less MIF than non-stimulated cells,
suggesting that trophoblast cells downregulate the secretion of MIF
by monocytes in the absence of infection, contributing to the
establishment of a favorable microenvironment for the mainte-
nance of pregnancy. In contrast, THP-1 cells, when stimulated with
supernatant of infected BeWo cells, secreted higher levels of MIF
than the controls (no stimulus or uninfected BeWo cell superna-
tant), suggesting that the parasite in trophoblast cells induces
release of soluble factors that are able to upregulate the secretion of
MIF by monocytes. Additionally, THP-1 cells infected without
stimulus secreted moreMIF than those infected after stimulus with
supernatants from infected or uninfected BeWo cells, suggesting
that trophoblast cells, even when infected, induce infected mono-
cytes to secrete less MIF, thereby helping to minimize the pro-
inﬂammatory response induced by the parasite. This could help
to control the parasitism and maintain the pregnancy, since MIF, at
appropriate concentrations, induces inﬂammatory responses that
can provide protection against infections and ensure rapid and
efﬁcient elimination of parasites, as required for the establishment
of pregnancy [25].
Our results also showed that IL-12 production by THP-1 cells was
increased after stimulation with infected BeWo cell supernatants,
Fig. 4. Cytokine signatures secreted by THP-1 cells, infected or not with T. gondii, after stimulation with supernatants of uninfected or infected BeWo cells. The results are expressed
in frequency of high cytokine levels (%) calculated from the global medians for each cytokine, which were then used as cut-off. Frequencies were considered relevant when higher
than 50%.
Fig. 5. (A) Toxoplasma gondii intracellular proliferation in THP-1 cells after stimulation with supernatants from uninfected or infected BeWo cells. Infected THP-1 cells without
treatment with supernatants from uninfected or infected BeWo cells served as control. Data are expressed as mean  SD of the number of parasites in three independent
experiments performed in triplicate. (*) Signiﬁcant differences in relation to the control; (C) signiﬁcant differences between non-infected and infected BeWo cell supernatants
(P < 0.05; Student’s t test). (B) Relationship between the secretion of IL-6 by THP-1 cells and the proliferation of T. gondii in cells non-stimulated (control) or stimulated with
supernatants of uninfected or infected BeWo cells. (*) Signiﬁcant differences in relation to the control. (#) Signiﬁcant differences between non-infected and infected BeWo cell
supernatants (P < 0.05; Student’s t test). (C) T. gondii intracellular proliferation in THP-1 cells treated with anti-IL-6 antibody. THP-1 cells infected with T. gondii and not treated with
anti-IL-6 antibody served as control. (*) Signiﬁcant differences in relation to the control (P < 0.05; Student’s t test).
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Fig. 6. (A) Toxoplasma gondii intracellular proliferation in THP-1 cells after stimulation
with neutralized supernatants from uninfected or infected BeWo cells. The superna-
tants were separately neutralized with 10 mg/mL of anti-IL-6, anti-MIF or anti-TGF-b1
antibodies. THP-1 cells stimulated with non-neutralized supernatants served as
control. Data are expressed as mean  SD of the number of parasites in three inde-
pendent experiments performed in triplicate. The dotted line represents the number of
tachyzoites in THP-1 cells without any stimulus. (*) Signiﬁcant differences in relation to
the control (P < 0.05; Student’s t test). (B) T. gondii intracellular proliferation in THP-1
cells treated with rIL-6 (25, 50 and 100 pg/mL), rMIF (2000, 4000 and 8000 pg/mL) or
rTGF-b1 (500, 1000 and 2000 pg/mL). THP-1 cells cultured without any treatment
served as control. Data are expressed as mean  SD of the number of parasites in three
independent experiments performed in triplicate. (*) Signiﬁcant differences in relation
to the control (P < 0.05; Student’s t test).
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of the parasite and soluble factors secreted by BeWo cells in this
effect. In infected THP-1 cells, however, the stimuluswith BeWo cell
supernatants, infected or not, downregulated the secretion of IL-12
by THP-1 cells, suggesting an important mechanism of interaction
between trophoblast cells and monocytes to establish a favorable
microenvironment for the development and maintenance of preg-
nancy even in the presence of infection.
Interleukin-6 is fundamental in the process of embryo implan-
tation and in the early stages of pregnancy, since IL-6/ mice
showed reduced fertility and a decrease in viable implantation sites
[26]. IL-6 can also act at the maternalefetal interface to alter many of
the parameters that inﬂuence fetal growth, including nutrient
transfer, anoxia and vascular permeability [27,28]. In this study we
demonstrated that THP-1 cells, infected or not with T. gondii,
secreted higher levels of IL-6 after stimulation with uninfected or
infected BeWo cell supernatants than thosewithout stimulus. As this
cytokine may facilitate the growth and invasion of the trophoblast
through the decidual tissue [10], these results demonstrating that
trophoblast cells stimulate the secretion of IL-6 by THP-1 cells
suggest that these innate immune cells may play a modulatory role
at the implantation site, promoting appropriate signals that facilitate
trophoblast growth and invasion. The presence of T. gondii in BeWo
cells also stimulates them to release soluble factors that can upre-
gulate the production of IL-6 by THP-1 cells. Additionally, IL-17Awas
also secreted at increased levels by infected THP-1 cells stimulatedwith infected BeWo cell supernatant. These data reinforce the role of
IL-17A in the control of T. gondii, since this cytokine is important in
the combat of several kinds of pathogens [29,30].
IL-10 and TGF-b1 are regulatory cytokines essential for tolerance
of the fetus during pregnancy [31]. Our results showed that BeWo
cells secrete soluble factors that downregulate the secretion of TGF-
b1 by THP-1 cells. This downmodulation was potentiated in THP-1
cells infected by T. gondii, suggesting that TGF-b1 levels decreased
as a consequence of the action of pro-inﬂammatory cytokines
induced by the parasite and required to control the infection. In
contrast, BeWo cell supernatants were able to upregulate the
secretion of IL-10 by THP-1 cells even in the presence of T. gondii,
contributing to the establishment of a typically anti-inﬂammatory
microenvironment [32].
The present study also showed that factors secreted by BeWo
cells were able to regulate THP-1 cell activity, rendering themmore
able to control T. gondii growth. Furthermore, the production of IL-6
by THP-1 cells was associated with parasitism control. Similar
results have been seen in other studies, demonstrating that IL-6
participates in the protective immune response against Giardia
duodenalis [33] and Trypanosoma cruzi [34], and plays a critical role
in limiting microbial multiplication during early infection with
Listeria monocytogenes [35], Vaccinia virus [36] and Candida albicans
[37]. Others authors demonstrated that IL-6/ mice infected with
T. gondii showed impaired development of the innate pro-
inﬂammatory response, which is essential for limiting parasite
replication [24]. Another study using IL-6/ mice also showed
a protective effect of IL-6 in cases of encephalitis caused by T. gondii
infection [38]. IL-6 is also important in the inﬂammation resolution,
since this cytokine can stimulate the secretion of IL-10 [39]. This
important relationship was observed in studies of human Plasmo-
dium falciparum showing that elevated IL-6/IL-10 ratios in the
plasma due to relative IL-10 deﬁciencies led to a fatal outcome of
severemalaria [40]. Taken together, these cytokines can balance the
intensity of immune responses.
In an attempt to identify which soluble factors secreted by BeWo
cells would be regulating THP-1 cell functional activity, we per-
formed experiments with neutralized BeWo cell supernatants or
added recombinant cytokines. We veriﬁed that IL-6 and MIF
secreted by BeWo cells, as well these added recombinant cytokines,
were able to regulate the THP-1 cell response, rendering themmore
competent to control T. gondii growth. In contrast, TGF-b1 secreted
by BeWo cells did not show any effect on T. gondii proliferation in
THP-1 cells. Some mechanisms of MIF and IL-6 actions can be
hypothesized to explain how these cytokines can control T. gondii
infection.MIF is critical for host resistance to infection, and our
group has investigated the role of this cytokine in the fetale
maternal interface over the last years [16,22]. However, the role
of its signaling pathway during the infection is not completely
understood so far. MIF can suppress the activity of p53 trough the
activation of ERK (extracellular signal-regulated kinases) that
results in an inhibition of the apoptotic process and consequently
promotes a long inﬂammatory response [41]. MIF is also respon-
sible for the upregulation of the toll-like receptor 4 (TLR4) and the
activation of transcription factors like Elk1 and Ets, which have an
important action by mediating the innate immunity against path-
ogens [42]. Moreover, MIF can activate NF-kB (Nuclear Factor
Kappa-B), a transcriptional factor involved in regulating expression
of many pro-inﬂammatory cytokines and this signaling pathway
participates in the defense against several infections [43].
Interleukin-6, in turn, induces IDO (indoleamina 2,3 dioxigenase)
expression trough JAK/STAT pathway [44]. As IDO is an enzyme
responsible for the degradation of tryptophan, which is an essential
amino acid to T. gondii proliferation, IL-6 can control T. gondii
growth due to IDO upregulation. However, future studies are
A.S. Castro et al. / Placenta 34 (2013) 240e247 247necessary to conﬁrm these hypotheses. Thus, our results reinforce
the idea that soluble factors present in a speciﬁc microenvironment
alter the activity of immune cells in this microenvironment [45].
In conclusion, the present work demonstrated that trophoblast
cells are able to regulate the functional activity of THP-1 cells,
altering the pattern of cytokines secretion by these cells of the
innate immune system as well as their susceptibility to infection by
T. gondii at the maternalefetal interface. Together, our data suggest
that similar phenomena may occur in vivo; thus, trophoblast cells
may interact with monocytes present in the decidua and regulate
their activity to ensure the maintenance of pregnancy. Therefore,
the control of T. gondii infection in the placental microenvironment
depends on the delicate relationship between innate immune cells
and trophoblast cells.
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